- Think of it: sudden, maximal-at-onset chest/back pain + pulse or BP difference (>20 mmHg between arms) or neuro deficit or new AR murmur or hypotension.
- CTA chest/abdomen/pelvis now. Unstable → bedside TEE (or TTE for flap, effusion, AR) on the way to the OR.
- Anti-impulse therapy: IV β-blocker first (esmolol or labetalol) → HR <60 → then vasodilator (nicardipine/nitroprusside) → SBP <120 within the first hour, as fast as tolerated. Opioids for pain.
- Type A (ascending involved) → emergency cardiac surgery. Mortality rises every hour.
- Type B uncomplicated → ICU, medical therapy (± TEVAR later). Complicated (malperfusion, rupture, refractory pain/HTN, rapid growth) → TEVAR.
- No anticoagulation, no antiplatelets, no thrombolytics until dissection is ruled out.
Pathophysiology in 60 seconds
⌄
Red line = the intimal flap. Type A (any ascending involvement, wherever the tear starts) can rupture into the pericardium (tamponade), tear the aortic valve (acute AR) or dissect a coronary — usually the RCA → inferior STEMI. Type B threatens what branches off downstream: gut, kidneys, spinal cord, legs.
- A tear in the intima lets blood split the media → a false lumen runs along the aorta.
- The force that drives it is dP/dt — how fast pressure rises with each beat. That is why we slow the heart rate first, then lower BP.
- Complications follow the anatomy: pericardium (tamponade), aortic valve (acute AR), coronaries (usually RCA → inferior STEMI), carotids (stroke), subclavian (pulse deficit), spinal arteries (paraplegia), mesenteric/renal (gut ischemia, AKI), iliacs (cold leg).
- Acute aortic syndromes also include intramural hematoma (IMH, bleeding in the wall without a flap) and penetrating atherosclerotic ulcer (PAU). Same urgency rules by location.
Risk factors: hypertension (most common) · cocaine/meth · bicuspid aortic valve · Marfan, Loeys-Dietz, vascular Ehlers-Danlos, Turner · known aneurysm · recent aortic surgery/cath · pregnancy (3rd trimester) · family history · giant cell arteritis · weightlifting · fluoroquinolones (association).
Diagnosis
⌄
| ADD risk score (1 point per category) | Examples |
|---|---|
| High-risk conditions | Marfan/connective tissue disease, family history, known aortic valve disease or aneurysm, recent aortic manipulation |
| High-risk pain | Abrupt, severe, tearing/ripping chest, back or abdominal pain |
| High-risk exam | Pulse deficit / BP differential, focal neuro deficit + pain, new AR murmur + pain, hypotension/shock |
- Score 2–3 → go straight to CTA.
- Score 0–1 → consider D-dimer; <500 ng/mL makes dissection unlikely (ADvISED). Positive D-dimer or high suspicion → CTA.
| Test | Role |
|---|---|
| CTA chest/abd/pelvis | First line. Shows type, extent, branch involvement |
| TEE | Unstable patient, in ED/OR. Also shows AR, tamponade |
| TTE | Quick clues: flap in the root, pericardial effusion, AR. Cannot rule it out |
| MRI | Stable patients, follow-up, contrast allergy |
| CXR | Widened mediastinum in a minority — a normal CXR does not rule out |
| ECG | Normal or nonspecific in most; inferior STEMI if the RCA is involved |
STEMI + back pain + pulse deficit = dissection until proven otherwise. Lysis or heparin can be fatal. Get a quick bedside echo or CTA before the cath lab.
Workup
⌄
Two large-bore IVs · type and crossmatch · CBC, BMP, lactate (malperfusion), troponin, coags · ECG · BP in both arms · arterial line (right radial usually, unless the right subclavian is involved) · urine output · serial neuro and limb exams · call cardiothoracic/vascular surgery early.
Management
⌄
| Step | Drug | Typical adult dose |
|---|---|---|
| 1. Rate (HR <60) | Esmolol | 0.5–1 mg/kg IV load → 50–300 mcg/kg/min |
| Labetalol | 20 mg IV → 20–80 mg q10 min, or 0.5–2 mg/min | |
| β-blocker contraindicated | Diltiazem 0.25 mg/kg IV or verapamil | |
| 2. BP (SBP <120) | Nicardipine | 5 mg/h, ↑2.5 mg/h q5–15 min, max 15 |
| Nitroprusside | 0.3–0.5 mcg/kg/min, titrate (max 10) | |
| Clevidipine | 1–2 mg/h, titrate | |
| 3. Pain | Fentanyl / morphine | Pain drives catecholamines and BP |
- Emergency surgery (ascending ± arch replacement; valve resuspension or replacement).
- Hypotension → think tamponade, severe AR, rupture, coronary dissection → straight to the OR.
- Tamponade: surgery is the fix. If arrest is imminent and surgery is not available, small controlled pericardial drainage only to restore minimal perfusion — full drainage can cause rupture.
- Very elderly/comatose/major stroke → individual decision with surgery.
- Uncomplicated → ICU, anti-impulse therapy, serial imaging. TEVAR can be considered in selected patients with high-risk features.
- Complicated (malperfusion of gut/kidneys/legs/cord, rupture, expansion, refractory pain or HTN) → TEVAR preferred over open repair.
- Spinal cord protection during TEVAR: lumbar drain in high-risk cases; keep MAP up.
- BP <130/80 (lower if tolerated) and HR control — β-blocker backbone (± ARB).
- Imaging (CT/MRI) at ~1, 6 and 12 months, then yearly.
- Avoid heavy isometric lifting, stimulants. Treat smoking, lipids.
- Genetic testing and first-degree relative screening in young patients or family history.
Typical adult doses. Never start a vasodilator before the heart rate is controlled — reflex tachycardia raises dP/dt.
Pitfalls
⌄
- Thrombolysis or heparin for "STEMI" or "stroke" that is really a dissection.
- Vasodilator first → reflex tachycardia → tear propagates.
- Trusting a normal CXR or a normal D-dimer in a high-risk patient.
- Measuring BP only in the arm with the pulse deficit (falsely low → undertreatment).
- Missing malperfusion: check lactate, legs, belly, urine, neuro every hour early on.
Board corner
⌄
| Stem | Answer |
|---|---|
| Tearing pain, BP 180/100 right arm, 140/80 left | Aortic dissection → CTA |
| Tall young man, lens dislocation, chest pain | Marfan → dissection |
| Type A on CT, BP 90/50, muffled heart sounds | Tamponade → emergency surgery |
| Inferior STEMI + diastolic murmur + back pain | Type A involving RCA |
| Type B with rising lactate and abdominal pain | Mesenteric malperfusion → TEVAR |
| First drug for dissection, HR 110, SBP 180 | IV esmolol (or labetalol) |
| Type B, pain-free, stable on drugs | Medical therapy, ICU, serial imaging |
References
⌄
- Isselbacher EM, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease. Circulation. 2022;146:e334.
- Mazzolai L, et al. 2024 ESC guidelines for peripheral arterial and aortic diseases. Eur Heart J. 2024;45:3538.
- Nazerian P, et al. ADvISED: ADD-RS + D-dimer to rule out acute aortic syndromes. Circulation. 2018;137:250.
- Jones DW, et al. 2025 AHA/ACC high blood pressure guideline. Hypertension. 2025;82:e212.
- MGH White Book 2019–2020: Aortic disease (structure).